Kaneh Bosm does not say why stock is up, but ...
KANEH BOSM BioTechnolgy Inc. has confirmed that the company’s management is unaware of any material change in the company’s operations that would account for the recent increase in market activity. The company would also like to report that it has been searching for marijuana-related projects to acquire as per the company’s Canadian Securities Exchange medical marijuana status. The company will be looking at new opportunities that will potentially in crease share holder value and will report any material events and developments as they come due.
We seek Safe Harbor.
Kent E Ausburn, Roelof de Jonge, Matthew Wyatt Lechtzier, Michael Martinz
(KBB) Shares: 13,183,870